Biosynthetic proteins targeting the SARS-CoV-2 spike as anti-virals.
PLoS Pathog
; 18(9): e1010799, 2022 09.
Article
in En
| MEDLINE
| ID: mdl-36067253
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Recombinant Fusion Proteins
/
Spike Glycoprotein, Coronavirus
/
Angiotensin-Converting Enzyme 2
/
COVID-19 Drug Treatment
Limits:
Humans
Language:
En
Journal:
PLoS Pathog
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: